December 12, 2025

Help Needed. Help Avoided. Here’s Why.

Many older Americans qualify for disability accommodations but reject the label — limiting access to care, support, and legal protections.

KFF Health News

December 09, 2025

Top 10 States to Practice Psychiatry

Looking for a place where your psychiatry practice—and your peace of mind—can thrive? These 10 states stand out for pay, demand, and opportunity.

Conexiant

December 03, 2025

Are New Incentives Boosting Births?

A report on recent federal pronatalist policy initiatives, proposed IVF access measures, and associated government actions involving women’s and children’s health programs in the US.

KFF Health News

December 01, 2025

Psychiatry Editors Published More During Tenure, Study

An exploratory study suggests psychiatry Editors-in-Chief self-publish more often—and more frequently than their medicine counterparts—highlighting ongoing calls for clearer safeguards in editorial oversight.

Conexiant

January 14, 2025

Lifetime Dementia Risk: 42% Post-Age 55

"Our results suggest that the current lifetime risk of dementia may be substantially higher than previously thought."

Conexiant

May 09, 2024

Time of Day May Impact Aging Predictions

New study reveals that epigenetic age predictions fluctuate significantly throughout the day, emphasizing the need to consider timing in aging assessments.

Conexiant

June 05, 2024

Body Roundness Index Predicts Mortality: Key Risks Revealed

A recent study found that extreme Body Roundness Index levels significantly increase the risk of all-cause mortality among US adults, highlighting the importance of this measure in health assessments.

Conexiant

February 06, 2025

Meds that May Increase Dementia Risk

Antimicrobials, anti-inflammatories, and vaccines were associated with reduced dementia risk, while antipsychotics, antidepressants, and diabetes medications were frequently associated with increased dementia risk.

Conexiant

June 11, 2024

Omega-3 Supplementation and Its Effects on Osteoarthritis

Omega-3 supplementation has shown potential in reducing inflammation and improving symptoms in osteoarthritis, though further research is needed to confirm its efficacy.

Conexiant